1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	devastating	_	_	JJ	_	_	_	_	_
3	threat	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	antimicrobial	_	_	JJ	_	_	_	_	_
6	resistance	_	_	NN	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	AMR	_	_	NNP	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	global	_	_	JJ	_	_	_	_	_
12	human	_	_	JJ	_	_	_	_	_
13	health	_	_	NN	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	unquestionable	_	_	JJ	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Antimicrobials	_	_	NNS	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	losing	_	_	VBG	_	_	_	_	_
4	their	_	_	PRP$	_	_	_	_	_
5	effectiveness	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	treating	_	_	VBG	_	_	_	_	_
8	infections	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	due	_	_	JJ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	rapid	_	_	JJ	_	_	_	_	_
14	emergence	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	AMR	_	_	NNP	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	drying	_	_	NN	_	_	_	_	_
20	up	_	_	RP	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	antimicrobial	_	_	JJ	_	_	_	_	_
23	pipelines	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	difficult-to-treat	_	_	JJ	_	_	_	_	_
3	AMR	_	_	NN	_	_	_	_	_
4	infections	_	_	NNS	_	_	_	_	_
5	require	_	_	VBP	_	_	_	_	_
6	longer	_	_	JJR	_	_	_	_	_
7	hospital	_	_	JJ	_	_	_	_	_
8	stays	_	_	NNS	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	more	_	_	RBR	_	_	_	_	_
11	costly	_	_	JJ	_	_	_	_	_
12	treatment	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	increase	_	_	VB	_	_	_	_	_
15	morbidity	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	mortality	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	reduce	_	_	VB	_	_	_	_	_
21	productivity	_	_	NN	_	_	_	_	_
22	;	_	_	:	_	_	_	_	_
23	therefore	_	_	RB	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	increasing	_	_	VBG	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	economic	_	_	JJ	_	_	_	_	_
28	burden	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	countries	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	years	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	this	_	_	DT	_	_	_	_	_
6	global	_	_	JJ	_	_	_	_	_
7	health	_	_	NN	_	_	_	_	_
8	crisis	_	_	NN	_	_	_	_	_
9	has	_	_	VBZ	_	_	_	_	_
10	been	_	_	VBN	_	_	_	_	_
11	gaining	_	_	VBG	_	_	_	_	_
12	much	_	_	JJ	_	_	_	_	_
13	attention	_	_	NN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	Malaysia	_	_	NNP	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	Malaysia	_	_	NNP	_	_	_	_	_
19	has	_	_	VBZ	_	_	_	_	_
20	been	_	_	VBN	_	_	_	_	_
21	striving	_	_	VBG	_	_	_	_	_
22	hard	_	_	RB	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	combat	_	_	VB	_	_	_	_	_
25	it	_	_	PRP	_	_	_	_	_
26	via	_	_	IN	_	_	_	_	_
27	different	_	_	JJ	_	_	_	_	_
28	approaches	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	major	_	_	JJ	_	_	_	_	_
3	contributing	_	_	VBG	_	_	_	_	_
4	factors	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	AMR	_	_	NNP	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	known	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	overuse	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	misuse	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	antimicrobials	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Antibiotic	_	_	JJ	_	_	_	_	_
2	consumption	_	_	NN	_	_	_	_	_
3	by	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	elderly	_	_	JJ	_	_	_	_	_
6	population	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	found	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	between	_	_	IN	_	_	_	_	_
12	11	_	_	CD	_	_	_	_	_
13	%	_	_	NN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	45	_	_	CD	_	_	_	_	_
16	%	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	significant	_	_	JJ	_	_	_	_	_
21	rise	_	_	NN	_	_	_	_	_
22	over	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	past	_	_	JJ	_	_	_	_	_
25	decade	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	As	_	_	RB	_	_	_	_	_
2	much	_	_	JJ	_	_	_	_	_
3	as	_	_	IN	_	_	_	_	_
4	18	_	_	CD	_	_	_	_	_
5	%	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	total	_	_	JJ	_	_	_	_	_
9	antibiotic	_	_	JJ	_	_	_	_	_
10	prescriptions	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	older	_	_	JJR	_	_	_	_	_
13	adults	_	_	NNS	_	_	_	_	_
14	was	_	_	VBD	_	_	_	_	_
15	unnecessary	_	_	JJ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	54	_	_	CD	_	_	_	_	_
19	%	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	them	_	_	PRP	_	_	_	_	_
22	prescribed	_	_	VBN	_	_	_	_	_
23	for	_	_	IN	_	_	_	_	_
24	acute	_	_	JJ	_	_	_	_	_
25	respiratory	_	_	JJ	_	_	_	_	_
26	conditions	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Healthcare	_	_	NN	_	_	_	_	_
2	providers	_	_	NNS	_	_	_	_	_
3	face	_	_	VBP	_	_	_	_	_
4	challenges	_	_	NNS	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	adequately	_	_	RB	_	_	_	_	_
7	diagnosing	_	_	VBG	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	managing	_	_	VBG	_	_	_	_	_
10	infections	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	this	_	_	DT	_	_	_	_	_
13	vulnerable	_	_	JJ	_	_	_	_	_
14	population	_	_	NN	_	_	_	_	_
15	because	_	_	IN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	altered	_	_	VBN	_	_	_	_	_
19	drug	_	_	NN	_	_	_	_	_
20	metabolism	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	this	_	_	DT	_	_	_	_	_
23	particular	_	_	JJ	_	_	_	_	_
24	group	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	common	_	_	JJ	_	_	_	_	_
28	occurrence	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	drug	_	_	NN	_	_	_	_	_
31	–	_	_	:	_	_	_	_	_
32	drug	_	_	NN	_	_	_	_	_
33	interactions	_	_	NNS	_	_	_	_	_
34	due	_	_	JJ	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	polypharmacy	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	lower	_	_	JJR	_	_	_	_	_
39	medication	_	_	NN	_	_	_	_	_
40	adherence	_	_	NN	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	Nursing	_	_	VBG	_	_	_	_	_
2	homes	_	_	NNS	_	_	_	_	_
3	or	_	_	CC	_	_	_	_	_
4	long	_	_	JJ	_	_	_	_	_
5	term	_	_	NN	_	_	_	_	_
6	care	_	_	NN	_	_	_	_	_
7	facilities	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	United	_	_	NNP	_	_	_	_	_
11	States	_	_	NNPS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	Australia	_	_	NNP	_	_	_	_	_
14	were	_	_	VBD	_	_	_	_	_
15	found	_	_	VBN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	reservoir	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	AMR	_	_	NNP	_	_	_	_	_
22	pathogens	_	_	NNS	_	_	_	_	_
23	due	_	_	JJ	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	excessive	_	_	JJ	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	inappropriate	_	_	JJ	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	prolonged	_	_	JJ	_	_	_	_	_
30	broad-spectrum	_	_	JJ	_	_	_	_	_
31	antimicrobial	_	_	JJ	_	_	_	_	_
32	use	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	inadequate	_	_	JJ	_	_	_	_	_
35	infection	_	_	NN	_	_	_	_	_
36	control	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	increased	_	_	VBN	_	_	_	_	_
39	risk	_	_	NN	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	pathogen	_	_	NN	_	_	_	_	_
42	colonization	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	prevalence	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	antimicrobial	_	_	JJ	_	_	_	_	_
5	consumption	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	nursing	_	_	NN	_	_	_	_	_
8	homes	_	_	NNS	_	_	_	_	_
9	was	_	_	VBD	_	_	_	_	_
10	reported	_	_	VBN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	11	_	_	CD	_	_	_	_	_
14	%	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	United	_	_	NNP	_	_	_	_	_
18	States	_	_	NNPS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	where	_	_	WRB	_	_	_	_	_
21	only	_	_	RB	_	_	_	_	_
22	66	_	_	CD	_	_	_	_	_
23	%	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	it	_	_	PRP	_	_	_	_	_
26	was	_	_	VBD	_	_	_	_	_
27	documented	_	_	VBN	_	_	_	_	_
28	for	_	_	IN	_	_	_	_	_
29	therapeutic	_	_	JJ	_	_	_	_	_
30	use	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	reported	_	_	VBN	_	_	_	_	_
3	incidence	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	infections	_	_	NNS	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	higher	_	_	JJR	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	older	_	_	JJR	_	_	_	_	_
11	adult	_	_	JJ	_	_	_	_	_
12	population	_	_	NN	_	_	_	_	_
13	because	_	_	IN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	presence	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	chronic	_	_	JJ	_	_	_	_	_
19	comorbidities	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	deteriorating	_	_	VBG	_	_	_	_	_
22	organ	_	_	NN	_	_	_	_	_
23	functions	_	_	NNS	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	reduced	_	_	VBN	_	_	_	_	_
26	host	_	_	NN	_	_	_	_	_
27	defence	_	_	NN	_	_	_	_	_
28	system	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Older	_	_	JJR	_	_	_	_	_
2	adults	_	_	NNS	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	have	_	_	VBP	_	_	_	_	_
5	poorer	_	_	JJR	_	_	_	_	_
6	outcomes	_	_	NNS	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	consequence	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	infections	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	including	_	_	VBG	_	_	_	_	_
14	higher	_	_	JJR	_	_	_	_	_
15	mortality	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	compared	_	_	VBN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	adults	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	other	_	_	JJ	_	_	_	_	_
22	age	_	_	NN	_	_	_	_	_
23	groups	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Atypical	_	_	JJ	_	_	_	_	_
2	clinical	_	_	JJ	_	_	_	_	_
3	presentations	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	infections	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	undertreatment	_	_	NN	_	_	_	_	_
8	or	_	_	CC	_	_	_	_	_
9	overtreatment	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	high	_	_	JJ	_	_	_	_	_
12	risk	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	multidrug-resistant	_	_	JJ	_	_	_	_	_
15	organism	_	_	NN	_	_	_	_	_
16	acquisition	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	rapid	_	_	JJ	_	_	_	_	_
19	disease	_	_	NN	_	_	_	_	_
20	progression	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	prolonged	_	_	JJ	_	_	_	_	_
23	recovery	_	_	NN	_	_	_	_	_
24	all	_	_	DT	_	_	_	_	_
25	contribute	_	_	VBP	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	poorer	_	_	JJR	_	_	_	_	_
28	outcomes	_	_	NNS	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	elderly	_	_	JJ	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	older	_	_	JJR	_	_	_	_	_
4	adults	_	_	NNS	_	_	_	_	_
5	who	_	_	WP	_	_	_	_	_
6	were	_	_	VBD	_	_	_	_	_
7	living	_	_	VBG	_	_	_	_	_
8	alone	_	_	RB	_	_	_	_	_
9	have	_	_	VBP	_	_	_	_	_
10	lower	_	_	JJR	_	_	_	_	_
11	health	_	_	NN	_	_	_	_	_
12	literacy	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	hence	_	_	RB	_	_	_	_	_
15	lower	_	_	JJR	_	_	_	_	_
16	self-management	_	_	NN	_	_	_	_	_
17	abilities	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	contributing	_	_	VBG	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	poorer	_	_	JJR	_	_	_	_	_
22	health	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	lack	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	knowledge	_	_	NN	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	antibiotic	_	_	JJ	_	_	_	_	_
7	use	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	general	_	_	JJ	_	_	_	_	_
11	public	_	_	NN	_	_	_	_	_
12	has	_	_	VBZ	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	reported	_	_	VBN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	more	_	_	JJR	_	_	_	_	_
18	than	_	_	IN	_	_	_	_	_
19	half	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	them	_	_	PRP	_	_	_	_	_
22	who	_	_	WP	_	_	_	_	_
23	thought	_	_	VBD	_	_	_	_	_
24	that	_	_	IN	_	_	_	_	_
25	antibiotics	_	_	NNS	_	_	_	_	_
26	are	_	_	VBP	_	_	_	_	_
27	useful	_	_	JJ	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	treating	_	_	VBG	_	_	_	_	_
30	viral	_	_	JJ	_	_	_	_	_
31	infections	_	_	NNS	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	about	_	_	RB	_	_	_	_	_
35	one	_	_	CD	_	_	_	_	_
36	half	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	them	_	_	PRP	_	_	_	_	_
39	would	_	_	MD	_	_	_	_	_
40	stop	_	_	VB	_	_	_	_	_
41	taking	_	_	VBG	_	_	_	_	_
42	antibiotics	_	_	NNS	_	_	_	_	_
43	when	_	_	WRB	_	_	_	_	_
44	they	_	_	PRP	_	_	_	_	_
45	felt	_	_	VBD	_	_	_	_	_
46	better	_	_	JJR	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Those	_	_	DT	_	_	_	_	_
2	who	_	_	WP	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	aware	_	_	JJ	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	antibiotic	_	_	JJ	_	_	_	_	_
7	resistance	_	_	NN	_	_	_	_	_
8	were	_	_	VBD	_	_	_	_	_
9	unaware	_	_	JJ	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	misuse	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	antibiotics	_	_	NNS	_	_	_	_	_
14	could	_	_	MD	_	_	_	_	_
15	lead	_	_	VB	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	this	_	_	DT	_	_	_	_	_
18	global	_	_	JJ	_	_	_	_	_
19	crisis	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Those	_	_	DT	_	_	_	_	_
2	who	_	_	WP	_	_	_	_	_
3	had	_	_	VBD	_	_	_	_	_
4	poor	_	_	JJ	_	_	_	_	_
5	knowledge	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	antibiotic	_	_	JJ	_	_	_	_	_
8	use	_	_	NN	_	_	_	_	_
9	were	_	_	VBD	_	_	_	_	_
10	associated	_	_	VBN	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	a	_	_	DT	_	_	_	_	_
13	higher	_	_	JJR	_	_	_	_	_
14	probability	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	antibiotic	_	_	JJ	_	_	_	_	_
17	self-medication	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	practices	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	using	_	_	VBG	_	_	_	_	_
22	leftover	_	_	JJ	_	_	_	_	_
23	antibiotics	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	sharing	_	_	VBG	_	_	_	_	_
26	antibiotics	_	_	NNS	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	keeping	_	_	VBG	_	_	_	_	_
29	antibiotics	_	_	NNS	_	_	_	_	_
30	for	_	_	IN	_	_	_	_	_
31	future	_	_	JJ	_	_	_	_	_
32	use	_	_	NN	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	stopping	_	_	VBG	_	_	_	_	_
35	antibiotics	_	_	NNS	_	_	_	_	_
36	when	_	_	WRB	_	_	_	_	_
37	symptoms	_	_	NNS	_	_	_	_	_
38	disappear	_	_	VBP	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Inappropriate	_	_	JJ	_	_	_	_	_
2	practices	_	_	NNS	_	_	_	_	_
3	related	_	_	VBN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	antibiotics	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	including	_	_	VBG	_	_	_	_	_
8	self-medication	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	were	_	_	VBD	_	_	_	_	_
11	reported	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	common	_	_	JJ	_	_	_	_	_
15	among	_	_	IN	_	_	_	_	_
16	older	_	_	JJR	_	_	_	_	_
17	adults	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	one	_	_	CD	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	considerable	_	_	JJ	_	_	_	_	_
7	proportion	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	older	_	_	JJR	_	_	_	_	_
10	adults	_	_	NNS	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	77.8	_	_	CD	_	_	_	_	_
13	%	_	_	NN	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	who	_	_	WP	_	_	_	_	_
16	had	_	_	VBD	_	_	_	_	_
17	antibiotic	_	_	JJ	_	_	_	_	_
18	use	_	_	NN	_	_	_	_	_
19	within	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	past	_	_	JJ	_	_	_	_	_
22	six	_	_	CD	_	_	_	_	_
23	months	_	_	NNS	_	_	_	_	_
24	were	_	_	VBD	_	_	_	_	_
25	found	_	_	VBN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	have	_	_	VB	_	_	_	_	_
28	experience	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	receiving	_	_	VBG	_	_	_	_	_
31	antibiotics	_	_	NNS	_	_	_	_	_
32	without	_	_	IN	_	_	_	_	_
33	prescriptions	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	only	_	_	RB	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	few	_	_	JJ	_	_	_	_	_
6	studies	_	_	NNS	_	_	_	_	_
7	reported	_	_	VBD	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	lack	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	knowledge	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	poor	_	_	JJ	_	_	_	_	_
14	attitude	_	_	NN	_	_	_	_	_
15	on	_	_	IN	_	_	_	_	_
16	antibiotic	_	_	JJ	_	_	_	_	_
17	use	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	resistance	_	_	NN	_	_	_	_	_
20	among	_	_	IN	_	_	_	_	_
21	older	_	_	JJR	_	_	_	_	_
22	adults	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Patients	_	_	NNS	_	_	_	_	_
2	who	_	_	WP	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	unaware	_	_	JJ	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	consequences	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	antibiotic	_	_	JJ	_	_	_	_	_
10	overuse	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	community	_	_	NN	_	_	_	_	_
14	were	_	_	VBD	_	_	_	_	_
15	found	_	_	VBN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	expect	_	_	VB	_	_	_	_	_
18	antibiotics	_	_	NNS	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	their	_	_	PRP$	_	_	_	_	_
21	prescriber	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Studies	_	_	NNS	_	_	_	_	_
2	have	_	_	VBP	_	_	_	_	_
3	found	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	those	_	_	DT	_	_	_	_	_
6	who	_	_	WP	_	_	_	_	_
7	incorrectly	_	_	RB	_	_	_	_	_
8	believed	_	_	VBD	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	antibiotics	_	_	NNS	_	_	_	_	_
11	will	_	_	MD	_	_	_	_	_
12	work	_	_	VB	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	viral	_	_	JJ	_	_	_	_	_
15	infections	_	_	NNS	_	_	_	_	_
16	were	_	_	VBD	_	_	_	_	_
17	more	_	_	RBR	_	_	_	_	_
18	likely	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	expect	_	_	VB	_	_	_	_	_
21	antibiotics	_	_	NNS	_	_	_	_	_
22	from	_	_	IN	_	_	_	_	_
23	prescribers	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Patients	_	_	NNS	_	_	_	_	_
2	’	_	_	POS	_	_	_	_	_
3	expectations	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	antibiotics	_	_	NNS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	found	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	be	_	_	VB	_	_	_	_	_
10	an	_	_	DT	_	_	_	_	_
11	important	_	_	JJ	_	_	_	_	_
12	predictor	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	antibiotic	_	_	JJ	_	_	_	_	_
15	prescribing	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Expectations	_	_	NNS	_	_	_	_	_
2	for	_	_	IN	_	_	_	_	_
3	antibiotics	_	_	NNS	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	common	_	_	JJ	_	_	_	_	_
6	cold	_	_	NN	_	_	_	_	_
7	were	_	_	VBD	_	_	_	_	_
8	found	_	_	VBN	_	_	_	_	_
9	among	_	_	IN	_	_	_	_	_
10	older	_	_	JJR	_	_	_	_	_
11	adults	_	_	NNS	_	_	_	_	_
12	when	_	_	WRB	_	_	_	_	_
13	they	_	_	PRP	_	_	_	_	_
14	felt	_	_	VBD	_	_	_	_	_
15	sick	_	_	JJ	_	_	_	_	_
16	enough	_	_	RB	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	visit	_	_	VB	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	physician	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	although	_	_	IN	_	_	_	_	_
23	most	_	_	JJS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	them	_	_	PRP	_	_	_	_	_
26	disagreed	_	_	VBD	_	_	_	_	_
27	that	_	_	IN	_	_	_	_	_
28	antibiotics	_	_	NNS	_	_	_	_	_
29	could	_	_	MD	_	_	_	_	_
30	speed	_	_	VB	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	recovery	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	our	_	_	PRP$	_	_	_	_	_
3	knowledge	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	many	_	_	JJ	_	_	_	_	_
6	studies	_	_	NNS	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	done	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	assess	_	_	VB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	knowledge	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	antibiotic	_	_	JJ	_	_	_	_	_
16	use	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	resistance	_	_	NN	_	_	_	_	_
19	;	_	_	:	_	_	_	_	_
20	however	_	_	RB	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	there	_	_	EX	_	_	_	_	_
23	has	_	_	VBZ	_	_	_	_	_
24	been	_	_	VBN	_	_	_	_	_
25	limited	_	_	VBN	_	_	_	_	_
26	research	_	_	NN	_	_	_	_	_
27	targeting	_	_	VBG	_	_	_	_	_
28	vulnerable	_	_	JJ	_	_	_	_	_
29	population	_	_	NN	_	_	_	_	_
30	groups	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	including	_	_	VBG	_	_	_	_	_
33	older	_	_	JJR	_	_	_	_	_
34	adults	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Due	_	_	JJ	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	paucity	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	information	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	this	_	_	DT	_	_	_	_	_
9	area	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	we	_	_	PRP	_	_	_	_	_
12	conducted	_	_	VBD	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	study	_	_	NN	_	_	_	_	_
15	among	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	older	_	_	JJR	_	_	_	_	_
18	adult	_	_	JJ	_	_	_	_	_
19	population	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	Malaysia	_	_	NNP	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	assess	_	_	VB	_	_	_	_	_
24	their	_	_	PRP$	_	_	_	_	_
25	knowledge	_	_	NN	_	_	_	_	_
26	on	_	_	IN	_	_	_	_	_
27	antibiotic	_	_	JJ	_	_	_	_	_
28	use	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	resistance	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	their	_	_	PRP$	_	_	_	_	_
33	expectations	_	_	NNS	_	_	_	_	_
34	towards	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	need	_	_	NN	_	_	_	_	_
37	for	_	_	IN	_	_	_	_	_
38	antibiotics	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	aimed	_	_	VBD	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	assess	_	_	VB	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	relationship	_	_	NN	_	_	_	_	_
9	between	_	_	IN	_	_	_	_	_
10	knowledge	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	expectations	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	practices	_	_	NNS	_	_	_	_	_
15	related	_	_	VBN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	antibiotic	_	_	JJ	_	_	_	_	_
18	use	_	_	NN	_	_	_	_	_
19	among	_	_	IN	_	_	_	_	_
20	older	_	_	JJR	_	_	_	_	_
21	adults	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_

